Risk Factors for Montelukast Treatment Failure in Step-Down Therapy for Controlled Asthma

References

• From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2010. Available at: http://www.ginasthma.org. Accessed: February 15, 2011.
   Google Scholar
• Expert Panel Report. 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007; 120(5 Suppl.):S94–S138.
   Web of Science ®Google Scholar
• British Guideline on the Management of Asthma—A National Clinical Guideline. 2011. Available at: http://www.brit-thoracic.org.uk/guidelines/asthma-guidelines.aspx. Accessed: February 15, 2011.
   Google Scholar
• Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 2000; 106(1):E8.
   PubMed Web of Science ®Google Scholar
• Wlodarczyk JH, Gibson PG, Caeser M. Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: a quantitative review. Ann Allergy Asthma Immunol 2008; 100(1):23–30.
   PubMed Web of Science ®Google Scholar
• Kelly HW, Van Natta ML, Covar RA, Tonascia J, Green RP, Strunk RC. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008; 122(1):e53–e61.
   PubMed Web of Science ®Google Scholar
• Adachi M, Kohno Y, Minoguchi K. Step-down and step-up therapy in moderate persistent asthma. Int Arch Allergy Immunol 2001; 124(1–3):414–416.
   PubMed Web of Science ®Google Scholar
• Bacharier LB. “Step-down” therapy for asthma: why, when, and how? J Allergy Clin Immunol 2002; 109(6):916–919.
   PubMed Web of Science ®Google Scholar
• Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 2003; 327(7420):891.
   PubMed Web of Science ®Google Scholar
• Foresi A, Mastropasqua B, Chetta A, D’Ippolito R, Testi R, Olivieri D, Pelucchi A. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma. Chest 2005; 127(1):117–124.
   PubMed Web of Science ®Google Scholar
• Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008; 63(5):453–462.
   PubMed Web of Science ®Google Scholar
• Polos PG. Montelukast is an effective monotherapy for mild asthma and for asthma with co-morbid allergic rhinitis. Prim Care Respir J 2006; 15(5):310–311.
   PubMedGoogle Scholar
• McIvor RA, Kaplan A, Koch C, Sampalis JS. Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial. Can Respir J 2009; 16(Suppl. A):11A–21A.
   Google Scholar
• Becker AB, Kuznetsova O, Vermeulen J, Soto-Quiros ME, Young B, Reiss TF, Dass SB, Knorr BA. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study. Ann Allergy Asthma Immunol 2006; 96(6):800–807.
   PubMed Web of Science ®Google Scholar
• Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: a prospective, randomized, double-blind, double-dummy, parallel-group study. Clin Ther 2008; 30(8):1492–1504.
   PubMed Web of Science ®Google Scholar
• Pedersen S, Agertoft L, Williams-Herman D, Kuznetsova O, Reiss TF, Knorr B, Dass SB, Wolthers OD. Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children. Pediatr Pulmonol 2007; 42(9):838–843.
   PubMed Web of Science ®Google Scholar
• Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol 2007; 119(4):916–923.
   PubMed Web of Science ®Google Scholar
• Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007; 356(20):2027–2039.
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159(1):179–187.
   PubMed Web of Science ®Google Scholar
• Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 1998; 114(4):998–1007.
   PubMed Web of Science ®Google Scholar
• Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14(4):902–907.
   PubMed Web of Science ®Google Scholar
• Sullivan LM, Massaro JM, D’Agostino RB, Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004; 23(10):1631–1660.
   PubMed Web of Science ®Google Scholar
• Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86(2):420–428.
   PubMed Web of Science ®Google Scholar
• Leuppi JD, Salome CM, Jenkins CR, Anderson SD, Xuan W, Marks GB, Koskela H, Brannan JD, Freed R, Andersson M, Chan HK, Woolcock AJ. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163(2):406–412.
   PubMed Web of Science ®Google Scholar
• Belda J, Parameswaran K, Lemiere C, Kamada D, O‘Byrne PM, Hargreave FE. Predictors of loss of asthma control induced by corticosteroid withdrawal. Can Respir J 2006; 13(3):129–133.
   PubMedGoogle Scholar
• Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, Hustad CM, Edelman JM. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. Am J Med 2005; 118(6):649–657.
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115(2):233–242.
   PubMed Web of Science ®Google Scholar